{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:03:30Z","timestamp":1773291810411,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2009,2,14]],"date-time":"2009-02-14T00:00:00Z","timestamp":1234569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s11010-009-0038-0","type":"journal-article","created":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T10:51:04Z","timestamp":1234522264000},"page":"199-208","source":"Crossref","is-referenced-by-count":22,"title":["Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease"],"prefix":"10.1007","volume":"325","author":[{"given":"Makbule","family":"Aydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cahide","family":"Gokkusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Ozkok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feti","family":"Tulubas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Unlucerci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak","family":"Pamukcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berrin","family":"Umman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,14]]},"reference":[{"key":"38_CR1","first-page":"e85","volume":"113","author":"American Heart Association","year":"2006","unstructured":"American Heart Association (2006) Heart disease and stroke statistics-2006 update. A report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 113:e85\u2013e151. doi: 10.1161\/CIRCULATIONAHA.105.171600","journal-title":"Circulation"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.clinbiochem.2006.05.010","volume":"39","author":"M Kerkeni","year":"2006","unstructured":"Kerkeni M, Addad F, Chauffert M et al (2006) Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem 39:821\u2013825. doi: 10.1016\/j.clinbiochem.2006.05.010","journal-title":"Clin Biochem"},{"issue":"11","key":"38_CR3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4065\/83.11.1200","volume":"83","author":"RV Milani","year":"2008","unstructured":"Milani RV, Lavie CJ (2008) Homocysteine: the Rubik\u2019s cube of cardiovascular risk factors. Mayo Clin Proc 83(11):1200\u20131202","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"38_CR4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","volume":"83","author":"LL Humphrey","year":"2008","unstructured":"Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M (2008) Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 83(11):1203\u20131212","journal-title":"Mayo Clin Proc"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4615-5771-5_22","volume-title":"Homocysteine metabolism: from basic science to clinical medicine","author":"H Jakubowski","year":"1997","unstructured":"Jakubowski H (1997) Synthesis of homocysteine thiolactone in normal and malignant cells. In: Graham I, Refsum H, Rosenberg IH, Ueland PM (eds) Homocysteine metabolism: from basic science to clinical medicine. Kluwer Academic Publishers, Boston, pp 157\u2013165"},{"key":"38_CR6","author":"O Stanojlovic","year":"2008","unstructured":"Stanojlovic O, Rasic-Markovic A, Hrncic D, Susic V, Macut D, Radosavljevic T, Djuric D (2008) Two types of seizures in homocysteine thiolactone-treated adult rats, behavioral and electroencephalographic study. Cell Mol Neurobiol. doi: 10.1007\/s10571-008-9324-8","journal-title":"Cell Mol Neurobiol"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, Jacques PF et al (2002) Plasma homocysteine as a risk factor dementia and Alzheimer\u2019s disease. N Engl J Med 346:476\u2013483. doi: 10.1056\/NEJMoa011613","journal-title":"N Engl J Med"},{"key":"38_CR8","first-page":"414","volume":"43","author":"SS Kang","year":"1988","unstructured":"Kang SS, Zhau J, Wong PWK et al (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414\u2013421","journal-title":"Am J Hum Genet"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/euhj.1998.1340","volume":"20","author":"A Gardemann","year":"1999","unstructured":"Gardemann A, Weidemann H, Philipp M (1999) The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. Eur Heart J 20:584\u2013592. doi: 10.1053\/euhj.1998.1340","journal-title":"Eur Heart J"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111\u2013113. doi: 10.1038\/ng0595-111","journal-title":"Nat Genet"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)17742-3","volume":"365","author":"JP Casas","year":"2005","unstructured":"Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD (2005) Homocysteine and stroke: evidence on a causal link from Mendelian randomization. Lancet 365:224\u2013232","journal-title":"Lancet"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1389200052997339","volume":"6","author":"S Friso","year":"2005","unstructured":"Friso S, Choi SW (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6:37\u201346. doi: 10.2174\/1389200052997339","journal-title":"Curr Drug Metab"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archinte.160.4.422","volume":"160","author":"WG Christen","year":"2000","unstructured":"Christen WG, Ajani UA, Glynn RJ, Hennekens CH (2000) Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 160:422\u2013434. doi: 10.1001\/archinte.160.4.422","journal-title":"Arch Intern Med"},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/jn\/133.5.1281","volume":"133","author":"D Girelli","year":"2003","unstructured":"Girelli D, Martinelli N, Pizzolo F, Friso S, Olivieri O, Stranieri C et al (2003) The interaction between MTHFR 677 C\u00a0\u2192\u00a0T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr 133:1281\u20131285","journal-title":"J Nutr"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1161\/CIRCULATIONAHA.105.573923","volume":"112","author":"G Luca De","year":"2005","unstructured":"De Luca G, Suryapranata H, Gregorio G, Lange H, Chiariello M (2005) Homocysteine and its effects on in-stent restenosis. Circulation 112:e307\u2013e311. doi: 10.1161\/CIRCULATIONAHA.104.518837","journal-title":"Circulation"},{"key":"38_CR16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)01429-6","volume":"34","author":"O Rozenberg","year":"2003","unstructured":"Rozenberg O, Rosenblat M, Coleman R (2003) Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1- knockout mice. Free Radic Biol Med 34:774\u2013784. doi: 10.1016\/S0891-5849(02)01429-6","journal-title":"Free Radic Biol Med"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.87.1.45","volume":"87","author":"H Jakubowski","year":"2000","unstructured":"Jakubowski H, Zhang L, Bardeguez A, Aviv A (2000) Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 87:45\u201351","journal-title":"Circ Res"},{"key":"38_CR18","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","volume":"275","author":"H Jakubowski","year":"2000","unstructured":"Jakubowski H (2000) Calcium-dependent human serum homocysteine thiolactone hydrolase: a protective mechanism against protein N-homocysteinylation. J Biol Chem 275:3957\u20133962. doi: 10.1074\/jbc.275.6.3957","journal-title":"J Biol Chem"},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/01.STR.29.10.2043","volume":"29","author":"H Schmidt","year":"1998","unstructured":"Schmidt H, Schmidt R, Niederkorn K et al (1998) Paraoxonase PON1 polymorphism Leu-Met 54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 29:2043\u20132048","journal-title":"Stroke"},{"key":"38_CR20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2337\/diabetes.48.3.623","volume":"48","author":"M Pfohl","year":"1999","unstructured":"Pfohl M, Koch M, Enderle MD et al (1999) Paraoxonase 192 Glu\/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes. Diabetes 48:623\u2013627. doi: 10.2337\/diabetes.48.3.623","journal-title":"Diabetes"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10238-005-0060-9","volume":"5","author":"N Martinelli","year":"2005","unstructured":"Martinelli N, Girelli D, Olivieri O et al (2005) Interaction between metabolic syndrome and PON1 polymorphism as a determinant of the risk of coronary artery disease. Clin Exp Med 5:20\u201330. doi: 10.1007\/s10238-005-0060-9","journal-title":"Clin Exp Med"},{"key":"38_CR22","doi-asserted-by":"crossref","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. The National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42: 1206\u20131252 (JNC 7: Complete Reports)","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"issue":"Suppl 1","key":"38_CR23","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diacare.29.s1.06.s43","volume":"29","author":"American Diabetes Association","year":"2006","unstructured":"American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43\u2013S48","journal-title":"Diabetes Care"},{"key":"38_CR24","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report (2002) National Cholesterol Education Program National Heart, Lung, and Blood Institute National Institutes of Health NIH Publication No. 02-5215"},{"key":"38_CR25","first-page":"549","volume":"29","author":"B Vester","year":"1991","unstructured":"Vester B, Rasmussen K (1991) High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 29:549\u2013554","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"38_CR26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0378-4347(91)80407-4","volume":"565","author":"JB Ubbink","year":"1991","unstructured":"Ubbink JB, Vermaak WJH, Bissbort S (1991) Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr A 565:441\u2013446. doi: 10.1016\/0378-4347(91)80407-4","journal-title":"J Chromatogr A"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0003-2697(89)90424-7","volume":"180","author":"CE Furlong","year":"1989","unstructured":"Furlong CE, Richter RJ, Seidel SL (1989) Spectrophotometric assay for enzymatic hydrolysis of the active metabolites of chloropyrites and parathion by plasma paraoxonase\/arylesterase. Anal Biochem 180:242\u2013247. doi: 10.1016\/0003-2697(89)90424-7","journal-title":"Anal Biochem"},{"key":"38_CR28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. doi: 10.1093\/nar\/16.3.1215","journal-title":"Nucleic Acids Res"},{"key":"38_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0169-328X(02)00672-1","volume":"111","author":"I Kara","year":"2003","unstructured":"Kara I, Sazci A, Ergul E (2003) Association of the C677T and A1298C polymorphisms in the 5, 10 methylentetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 111:84\u201390. doi: 10.1016\/S0169-328X(02)00672-1","journal-title":"Brain Res Mol Brain Res"},{"key":"38_CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng0193-73","volume":"3","author":"R Humbert","year":"1993","unstructured":"Humbert R, Adler DA, Disteche CM et al (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73\u201376. doi: 10.1038\/ng0193-73","journal-title":"Nat Genet"},{"key":"38_CR31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.yexmp.2007.02.005","volume":"82","author":"T Angeline","year":"2007","unstructured":"Angeline T, Jeyaraj N, Tsongalia GJ (2007) MTHFR gene polymorphisms, B-vitamins and hyperhomocysteinemia in young and middle-aged acute myocardial infarction patients. Exp Mol Pathol 82:227\u2013233. doi: 10.1016\/j.yexmp.2007.02.005","journal-title":"Exp Mol Pathol"},{"key":"38_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00439-002-0859-3","volume":"112","author":"MG Andreassi","year":"2003","unstructured":"Andreassi MG, Botto N, Cocci F et al (2003) Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 112:171\u2013177","journal-title":"Hum Genet"},{"key":"38_CR33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/clinchem\/47.4.661","volume":"47","author":"NQ Hanson","year":"2001","unstructured":"Hanson NQ, Aras O, Yang F (2001) C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47:661\u2013666","journal-title":"Clin Chem"},{"key":"38_CR34","first-page":"117","volume":"28","author":"J Selhub","year":"2000","unstructured":"Selhub J, Jacques PF, Bostom AG (2000) Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev 28:117\u2013145","journal-title":"Public Health Rev"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/ajcn\/82.6.1320","volume":"82","author":"DJ Stott","year":"2005","unstructured":"Stott DJ, MacIntosh G, Lowe GD et al (2005) Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 82:1320\u20131326","journal-title":"Am J Clin Nutr"},{"key":"38_CR36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7143.1543","volume":"316","author":"R Clarke","year":"1998","unstructured":"Clarke R (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 316:894\u2013898","journal-title":"BMJ"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-006-9381-6","volume":"300","author":"D Djuric","year":"2007","unstructured":"Djuric D, Vusanovic A, Jakovljevic V (2007) The effects of folic acid and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart. Mol Cell Biochem 300:177\u2013183. doi: 10.1007\/s11010-006-9381-6","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"38_CR38","first-page":"39","volume":"50","author":"D Djuric","year":"2008","unstructured":"Djuric D, Jakovljevic V, Rasic-Markovic A, Djuric A, Stanojlovic O (2008) Homocysteine, folic acid and coronary artery disease: possible impact on prognosis and therapy. Indian J Chest Dis Allied Sci 50(1):39\u201348","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"38_CR39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7326\/0003-4819-131-5-199909070-00003","volume":"131","author":"J Selhub","year":"1999","unstructured":"Selhub J, Jacques PF, Rosenberg IH (1999) Serum total homocysteine concentrations in the third national health and nutrition examination survey (1991\u20131994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 131:331\u2013339","journal-title":"Ann Intern Med"},{"key":"38_CR40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/mnfr.200600020","volume":"50","author":"SS Melo","year":"2006","unstructured":"Melo SS, Persuhn DC, Meirelles MS et al (2006) G1793A polymorphisms in the methylenetetrahydrofolate gene: effect of folic acid on homocysteine levels. Mol Nutr Food Res 50:769\u2013774. doi: 10.1002\/mnfr.200600020","journal-title":"Mol Nutr Food Res"},{"key":"38_CR41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/mgme.2000.3027","volume":"71","author":"M Lucock","year":"2000","unstructured":"Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71:121\u2013138. doi: 10.1006\/mgme.2000.3027","journal-title":"Mol Genet Metab"},{"key":"38_CR42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ab.2004.11.035","volume":"337","author":"G Chwatko","year":"2005","unstructured":"Chwatko G, Jakubowski H (2005) The determination of homocysteine-thiolactone in human plasma. Anal Biochem 337:271\u2013277. doi: 10.1016\/j.ab.2004.11.035","journal-title":"Anal Biochem"},{"key":"38_CR43","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1515\/CCLM.2003.224","volume":"41","author":"H Jakubowski","year":"2003","unstructured":"Jakubowski H (2003) Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans. Clin Chem Lab Med 41:1462\u20131466. doi: 10.1515\/CCLM.2003.224","journal-title":"Clin Chem Lab Med"},{"key":"38_CR44","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hq0901.094247","volume":"21","author":"B Mackness","year":"2001","unstructured":"Mackness B, Davies GK, Turkie W et al (2001) Paraoxonase status in coronary heart disease are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21:1451\u20131457. doi: 10.1161\/hq0901.094247","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"38_CR45","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.ATV.20.9.2113","volume":"20","author":"M Tomas","year":"2000","unstructured":"Tomas M, Senti M, Garcia-Faria F et al (2000) Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 20:2113\u20132119","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"38_CR46","first-page":"CR536","volume":"14","author":"E Ozkok","year":"2008","unstructured":"Ozkok E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I (2008) Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55\/192 gene variants on coronary artery disease in Turkish patients. Med Sci Monit 14(10):CR536\u2013CR542","journal-title":"Med Sci Monit"},{"key":"38_CR47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cbf.1070","volume":"22","author":"B Agachan","year":"2004","unstructured":"Agachan B, Yilmaz H, Karaali Z, Isbir T (2004) Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non- insulin dependent diabetes mellitus. Cell Biochem Funct 22:163\u2013168. doi: 10.1002\/cbf.1070","journal-title":"Cell Biochem Funct"},{"key":"38_CR48","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/01.ATV.18.10.1611","volume":"18","author":"D Ombres","year":"1998","unstructured":"Ombres D, Pannitteri G, Montali A et al (1998) The gln-Arg 192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients. Arterioscler Thromb Vasc Biol 18:1611\u20131616","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"38_CR49","first-page":"4","volume":"52","author":"TB Domagala","year":"2006","unstructured":"Domagala TB, Lacinski M, Trzeciak WH et al (2006) The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status. Cell Mol Biol (Noisyle-grand) 52:4\u201310","journal-title":"Cell Mol Biol (Noisyle-grand)"},{"key":"38_CR50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","volume":"299","author":"T Bhattacharyya","year":"2008","unstructured":"Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, Fu X, Shao M, Brennan DM, Ellis SG, Brennan ML, Allayee H, Lusis AJ, Hazen SL (2008) Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299:1265\u20131276. doi: 10.1001\/jama.299.11.1265","journal-title":"JAMA"},{"key":"38_CR51","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/01.ATV.17.11.2935","volume":"17","author":"I Leviev","year":"1997","unstructured":"Leviev I, Negro F, James RW (1997) Two alleles of the human paraoxonase gene produce different amounts of mRNA: an explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler Thromb Vasc Biol 17:2935\u20132939","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"38_CR52","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.amjcard.2007.06.019","volume":"100","author":"BA Steinberg","year":"2007","unstructured":"Steinberg BA, Cannon CP, Hernandez AF et al (2007) Medical therapies and invasive treatments for coronary artery disease by body mass: the \u201cobesity paradox\u201d in the Get with the Guidelines database. Am J Cardiol 100:1331\u20131335. doi: 10.1016\/j.amjcard.2007.06.019","journal-title":"Am J Cardiol"},{"key":"38_CR53","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1172\/JCI118373","volume":"96","author":"M Serrato","year":"1995","unstructured":"Serrato M, Marian AJ (1995) A variant of human paraoxonase\/arylesterase (HUMPONA) gene is risk factor for coronary artery disease. J Clin Invest 96:3005\u20133008. doi: 10.1172\/JCI118373","journal-title":"J Clin Invest"},{"key":"38_CR54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.clinbiochem.2003.12.012","volume":"37","author":"S Campo","year":"2004","unstructured":"Campo S, Sardo MA, Trimarchi G et al (2004) The paraoxonase promoter polymorphism (\u2212107) T\u00a0>\u00a0C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients. Clin Biochem 37:388\u2013394. doi: 10.1016\/j.clinbiochem.2003.12.012","journal-title":"Clin Biochem"},{"key":"38_CR55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.ATV.15.1.89","volume":"15","author":"RA Hegele","year":"1995","unstructured":"Hegele RA, Brunt JH, Connelly PW (1995) A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler Thromb Vasc Biol 15:89\u201395","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"38_CR56","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(95)92709-3","volume":"346","author":"J Ruiz","year":"1995","unstructured":"Ruiz J, Blanche H, James RW (1995) Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346:869\u2013872. doi: 10.1016\/S0140-6736(95)92709-3","journal-title":"Lancet"},{"key":"38_CR57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1086\/301669","volume":"62","author":"DK Sanghera","year":"1998","unstructured":"Sanghera DK, Aston CE, Saha N, Kamboh MI (1998) DNA polymorphisms in two paraoxonase genes are associated with the risk of coronary heart disease. Am J Hum Genet 62:36\u201344. doi: 10.1086\/301669","journal-title":"Am J Hum Genet"},{"key":"38_CR58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","volume":"25","author":"RW Alexander","year":"1995","unstructured":"Alexander RW (1995) Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25:155\u2013161","journal-title":"Hypertension"},{"key":"38_CR59","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1161\/01.ATV.17.12.3565","volume":"17","author":"T Zama","year":"1997","unstructured":"Zama T, Murata M, Matsubara YK et al (1997) A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 17:3565\u20133569","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"38_CR60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/01.ATV.17.6.1067","volume":"17","author":"DK Sanghera","year":"1997","unstructured":"Sanghera DK, Saha N, Aston CE, Kamboh MI (1997) Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol 17:1067\u20131073","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"38_CR61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115\u2013126. doi: 10.1056\/NEJM199901143400207","journal-title":"N Engl J Med"},{"key":"38_CR62","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135\u20131143. doi: 10.1161\/hc0902.104353","journal-title":"Circulation"},{"key":"38_CR63","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","volume":"279","author":"J Danesh","year":"1998","unstructured":"Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279:1477\u20131482. doi: 10.1001\/jama.279.18.1477","journal-title":"JAMA"},{"key":"38_CR64","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.STR.32.4.917","volume":"32","author":"M Di Napoli","year":"2001","unstructured":"Di Napoli M, Papa F, Bocola V (2001) C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32:917\u2013924","journal-title":"Stroke"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-009-0038-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-009-0038-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-009-0038-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:34:16Z","timestamp":1684888456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-009-0038-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,14]]},"references-count":64,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11010-009-0038-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,14]]}}}